Extended adjuvant treatment with anastrozole: Results from the Austrian breast and colorectal cancer study group trial 6a (ABCSG-6a).

被引：0
|
作者：
Jakesz, R
Samonigg, H
Greil, R
Gnant, M
Schmid, M
Kwasny, W
Kubista, E
Mlineritsch, B
Tausch, C
Stierer, M
机构：
[1] Vienna Gen Hosp, Vienna, Austria
[2] Graz Univ, Graz, Austria
[3] Salzburg Hosp, Salzburg, Austria
[4] Wiener Neustadt Gen Hosp, Wiener Neustadt, Austria
[5] Univ Vienna, Vienna, Austria
[6] BHS Hosp Linz, Linz, Austria
[7] Hanusch Med Ctr, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：10S / 10S
页数：1
相关论文
共 50 条
  • [31] PHARE Trial results of subset analysis comparing 6 to 12 months of trastuzumab in adjuvant early breast cancer
    Pivot, X.
    Romieu, G.
    Bonnefoi, H.
    Pierga, J-Y
    Kerbrat, P.
    Guastalla, J-P
    Lortholary, A.
    Espie, M.
    Fumoleau, P.
    Khayat, D.
    Pauporte, I.
    Kramar, A.
    [J]. CANCER RESEARCH, 2012, 72
  • [32] Understanding divergent trial results of adjuvant CDK4/6 inhibitors for early stage breast cancer
    Cunningham, Niamh C.
    Turner, Nicholas C.
    [J]. CANCER CELL, 2021, 39 (03) : 307 - 309
  • [33] PHARE randomized trial final results comparing 6 to 12 months of trastuzumab in adjuvant early breast cancer
    Pivot, X.
    Romieu, G.
    Debled, M.
    Pierga, J-Y
    Kerbrat, P.
    Bachelot, T.
    Espie, M.
    Lortholary, A.
    Fumoleau, P.
    Serin, D.
    Jacquin, J-P
    Jouannaud, C.
    Rios, M.
    Abadie-Lacourtoisie, S.
    Venat-Bouvet, L.
    Cany, L.
    Catala, S.
    Khayat, D.
    Gambotti, L.
    Pauporte, I.
    Mercier, C. Faure
    Paget-Bailly, S.
    Henriques, J.
    Grouin, J-M
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [34] Prognostic and Predictive Value of Centrally Reviewed Ki67 Labeling Index in Postmenopausal Women with Endocrine-Responsive Breast Cancer: Results from Austrian Breast and Colorectal Cancer Study Group Trial 8
    Bago-Horvath, Z.
    Rudas, M.
    Jakesz, R.
    Dubsky, P.
    Singer, C. F.
    Dietze, O.
    Greil, R.
    Jelen, A.
    Offner, F.
    Lang, A.
    Gruber, C.
    Poestlberger, S.
    Gnant, M. F. X.
    Filipits, M.
    [J]. CANCER RESEARCH, 2010, 70
  • [35] Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
    Baum, M
    Buzdar, AU
    Cuzick, J
    Forbes, J
    Houghton, J
    Klijn, JGM
    Sahmoud, T
    [J]. LANCET, 2002, 359 (9324): : 2131 - 2139
  • [36] Prognostic Value of Number of Removed Lymph Nodes, Number of Involved Lymph Nodes, and Lymph Node Ratio in 7502 Breast Cancer Patients Enrolled onto Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
    Tausch, Christoph
    Taucher, Susanne
    Dubsky, Peter
    Seifert, Michael
    Reitsamer, Roland
    Kwasny, Werner
    Jakesz, Raimund
    Fitzal, Florian
    Filipcic, Lidija
    Fridrik, Michael
    Greil, Richard
    Gnant, Michael
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (06) : 1808 - 1817
  • [37] Prognostic Value of Number of Removed Lymph Nodes, Number of Involved Lymph Nodes, and Lymph Node Ratio in 7502 Breast Cancer Patients Enrolled onto Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
    Christoph Tausch
    Susanne Taucher
    Peter Dubsky
    Michael Seifert
    Roland Reitsamer
    Werner Kwasny
    Raimund Jakesz
    Florian Fitzal
    Lidija Filipcic
    Michael Fridrik
    Richard Greil
    Michael Gnant
    [J]. Annals of Surgical Oncology, 2012, 19 : 1808 - 1817
  • [38] ZOLEDRONIC ACID (ZOL) IMPROVES DISEASE-FREE (DFS) AND RECURRENCE-FREE SURVIVAL (RFS) IN PREMENOPAUSAL WOMEN WITH EARLY BREAST CANCER (ERBC) RECEIVING ADJUVANT ENDOCRINE THERAPY: MULTIVARIATE ANALYSIS OF EFFICACY DATA FROM THE AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP (ABCSG)-12
    Gnant, M.
    Mlineritsch, B.
    Schippinger, W.
    Luschin-Ebengreuth, G.
    Steger, G. G.
    Bjelic-Radisic, V.
    Jakesz, R.
    Kubista, E.
    Marth, C.
    Greil, R.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 44 - 44
  • [39] 6-YEAR RESULTS OF A CONTROLLED TRIAL OF TAMOXIFEN AS SINGLE ADJUVANT AGENT IN MANAGEMENT OF EARLY BREAST-CANCER
    WILSON, AJ
    BAUM, M
    BRINKLEY, DM
    DOSSETT, JA
    MCPHERSON, K
    PATTERSON, JS
    RUBENS, RD
    SMIDDY, FG
    STOLL, BA
    RICHARDS, D
    ELLIS, SH
    [J]. WORLD JOURNAL OF SURGERY, 1985, 9 (05) : 756 - 764
  • [40] Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
    Gnant, M.
    Mlineritsch, B.
    Stoeger, H.
    Luschin-Ebengreuth, G.
    Knauer, M.
    Moik, M.
    Jakesz, R.
    Seifert, M.
    Taucher, S.
    Bjelic-Radisic, V.
    Balic, M.
    Eidtmann, H.
    Eiermann, W.
    Steger, G.
    Kwasny, W.
    Dubsky, P.
    Selim, U.
    Fitzal, F.
    Hochreiner, G.
    Wette, V.
    Sevelda, P.
    Ploner, F.
    Bartsch, R.
    Fesl, C.
    Greil, R.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (02) : 313 - 320
12345